Skip to content

A study to evaluate the effectiveness of a community based intense lifestyle intervention program to facilitate the conversion of dysglycemia (abnormal glucose level) to normoglycemia (normal glucose level)

Randomized controlled trial to evaluate the effectiveness of a community based intense lifestyle intervention program to facilitate the regression to normoglycemia among women with isolated impaired fasting glucose in Kasaragod district, Kerala, India

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035289
Enrollment
448
Registered
2021-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Community based intense Lifestyle interventions: Intervention includes monthly session with group based sessions and individual based sessions for a period of 12 months. Group based ses

Sponsors

Wellcome Trust DBT India Alliance
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (I) Inclusion criteria for screening (stage 1): 1) Women aged 30-60 years, 2) able to read, write and speak Malayalam, the local language 3) consents to participate in the study, 4) not a known diabetic, 5) no prior history of GDM (II) Inclusion criteria for the trial (stage 4): Participants should satisfy all the inclusion criteria for screening and should be diagnosed with isolated impaired fasting glucose in OGTT.

Exclusion criteria

Exclusion criteria: (i) Exclusion criteria for screening: -Women with T2DM, diabetes in pregnancy -With prior history of GDM, having chronic illnesses/ disease conditions or on medications that alter glucose metabolism will be excluded. Women with mental illness based on ICD-10 classification44 will also be excluded (ii) Exclusion criteria for the trial: all exclusion criteria for screening and also the newly diagnosed with diabetes or diabetes in pregnancy will be excluded. A screening questionnaire will be used to ensure that participants meet the inclusion and exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Incidence of regression from iIFG to normoglycemia at 24 monthsTimepoint: Incidence of regression from iIFG to normoglycemia at 24 months

Secondary

MeasureTime frame
1. Glycemic level assessment 2. Lipid profile assessment 3. Blood pressure monitoring 4. Anthropometric assessments 5. Behavioral risk factor assessment 6. Psychosocial assessment 7. Other clinical assessments such as fat percentage and muscle massTimepoint: Assessments will be made at 24 months

Countries

India

Contacts

Public ContactElezebeth Mathews

Central University of Kerala

elezebethmathews@gmail.com9495221707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 19, 2026